A discovery by a scientist studying brain cancer at OMRF could be key to improving MS treatment.
robert
“Now is not the time to quit,” Local researchers address what happens after your vaccine
“You’re probably still going to be following a lot of the same guidelines,” said OMRF’s Dr. Hal Scofield.
Experts urge caution as Covid-19 haunts Halloween
Halloween 2020 offers a familiar fright: the risk of spreading the coronavirus.
OMRF brain tumor drug receives rare disease designations from the FDA
The drug treats fast-growing, deadly brain cancers with no effective treatment.
Presbyterian Health Foundation awards $4.6 million in new research grants
The Presbyterian Health Foundation has awarded nearly $4.6 million in biomedical research grants to OMRF and OUHSC.
Is the coronavirus here to stay?
Even after the pandemic subsides, the coronavirus is likely to join the list of contagious diseases that remain in circulation for decades to come.
